US2014010837A1PendingUtilityA1

Methods and Compositions for Preventing a Condition

53
Assignee: CYVAX INCPriority: Aug 9, 2010Filed: Sep 11, 2013Published: Jan 9, 2014
Est. expiryAug 9, 2030(~4.1 yrs left)· nominal 20-yr term from priority
Inventors:Richard Markham
A61P 37/02A61P 37/04A61P 33/00A61P 31/10A61P 33/06A61P 35/00A61P 25/28A61P 31/12A61P 31/04A61P 25/00A61K 2039/53A61K 2039/6031A61K 31/713A61K 39/015A61K 31/7105A61K 39/39A61K 2039/55522A61K 39/0011A61K 39/295C12N 15/62Y02A50/30
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein are methods, compositions, and kits for preventing, inhibiting, reducing the severity of, or treating a disease or condition. A pharmaceutical composition provided herein can comprise a nucleic acid sequence encoding an antigen fused to an immune cell product, e.g., MIP-3α, and an adjuvant. The antigen can be from a bacteria, virus, fungus, parasite, or cancer. The antigen can be an Alzheimer's disease antigen.

Claims

exact text as granted — not AI-modified
1 . A pharmaceutical composition comprising:
 a. a nucleic acid sequence encoding an antigen or a fragment thereof fused to macrophage inflammatory protein 3 alpha or a fragment thereof; and   b. an adjuvant.   
     
     
         2 - 98 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.